glp-1 enhancer Integrating Receptor Agonists into Modern Stroke Prevention: Evidence, Mechanisms, and Clinical Consideration—A Narrative Review Supergut GLP-1 Daily Support Prebiotic

Preclinical Evidence Animal studies demonstrate reproductive toxicity, including skeletal and visceral abnormalities, dose-dependent growth restriction, and embryonic death

A common question is whether GLP-1 drugs cause cancer, since early animal studies suggested a risk of thyroid tumors

Suicidal ideations - Bupropion can worsen suicidal thoughts in patients who have them, especially in children, adolescents, and young adults

GLP-1 receptor agonists as a class share similar mechanisms and therefore comparable digestive effects, though individual medications show some distinctions

A new sociomedical perspective shows how off-label use of GLP-1 drugs for slimness is redefining what counts as a healthy, responsible body, revealing hidden moral pressures and global inequalities behind the weight loss boom